BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 36884218)

  • 1. Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease.
    Sharma M; Leung D; Momenilandi M; Jones LCW; Pacillo L; James AE; Murrell JR; Delafontaine S; Maimaris J; Vaseghi-Shanjani M; Del Bel KL; Lu HY; Chua GT; Di Cesare S; Fornes O; Liu Z; Di Matteo G; Fu MP; Amodio D; Tam IYS; Chan GSW; Sharma AA; Dalmann J; van der Lee R; Blanchard-Rohner G; Lin S; Philippot Q; Richmond PA; Lee JJ; Matthews A; Seear M; Turvey AK; Philips RL; Brown-Whitehorn TF; Gray CJ; Izumi K; Treat JR; Wood KH; Lack J; Khleborodova A; Niemela JE; Yang X; Liang R; Kui L; Wong CSM; Poon GWK; Hoischen A; van der Made CI; Yang J; Chan KW; Rosa Duque JSD; Lee PPW; Ho MHK; Chung BHY; Le HTM; Yang W; Rohani P; Fouladvand A; Rokni-Zadeh H; Changi-Ashtiani M; Miryounesi M; Puel A; Shahrooei M; Finocchi A; Rossi P; Rivalta B; Cifaldi C; Novelli A; Passarelli C; Arasi S; Bullens D; Sauer K; Claeys T; Biggs CM; Morris EC; Rosenzweig SD; O'Shea JJ; Wasserman WW; Bedford HM; van Karnebeek CDM; Palma P; Burns SO; Meyts I; Casanova JL; Lyons JJ; Parvaneh N; Nguyen ATV; Cancrini C; Heimall J; Ahmed H; McKinnon ML; Lau YL; Béziat V; Turvey SE
    J Exp Med; 2023 May; 220(5):. PubMed ID: 36884218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyond.
    ;
    Trends Immunol; 2024 Feb; 45(2):138-153. PubMed ID: 38238227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT6 gain-of-function variant exacerbates multiple allergic symptoms.
    Takeuchi I; Yanagi K; Takada S; Uchiyama T; Igarashi A; Motomura K; Hayashi Y; Nagano N; Matsuoka R; Sugiyama H; Yoshioka T; Saito H; Kawai T; Miyaji Y; Inuzuka Y; Matsubara Y; Ohya Y; Shimizu T; Matsumoto K; Arai K; Nomura I; Kaname T; Morita H
    J Allergy Clin Immunol; 2023 May; 151(5):1402-1409.e6. PubMed ID: 36538978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A germline STAT6 gain-of-function variant is associated with early-onset allergies.
    Suratannon N; Ittiwut C; Dik WA; Ittiwut R; Meesilpavikkai K; Israsena N; Ingrungruanglert P; Dalm VASH; van Daele PLA; Sanpavat A; Chaijitraruch N; Schrijver B; Buranapraditkun S; Porntaveetus T; Swagemakers SMA; IJspeert H; Palaga T; Suphapeetiporn K; van der Spek PJ; Hirankarn N; Chatchatee P; Martin van Hagen P; Shotelersuk V
    J Allergy Clin Immunol; 2023 Feb; 151(2):565-571.e9. PubMed ID: 36216080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autosomal Dominant STAT6 Gain of Function Causes Severe Atopy Associated with Lymphoma.
    Minskaia E; Maimaris J; Jenkins P; Albuquerque AS; Hong Y; Eleftheriou D; Gilmour KC; Grace R; Moreira F; Grimbacher B; ; Morris EC; Burns SO
    J Clin Immunol; 2023 Oct; 43(7):1611-1622. PubMed ID: 37316763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe allergic dysregulation due to a gain of function mutation in the transcription factor STAT6.
    Baris S; Benamar M; Chen Q; Catak MC; Martínez-Blanco M; Wang M; Fong J; Massaad MJ; Sefer AP; Kara A; Babayeva R; Eltan SB; Yucelten AD; Bozkurtlar E; Cinel L; Karakoc-Aydiner E; Zheng Y; Wu H; Ozen A; Schmitz-Abe K; Chatila TA
    J Allergy Clin Immunol; 2023 Jul; 152(1):182-194.e7. PubMed ID: 36758835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage and association studies of STAT6 gene polymorphisms and allergic diseases.
    Tamura K; Suzuki M; Arakawa H; Tokuyama K; Morikawa A
    Int Arch Allergy Immunol; 2003 May; 131(1):33-8. PubMed ID: 12759487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of interleukin (IL)-4 receptor alpha and signal transducer and activator of transcription-6 (Stat6) are associated with increased IL-4Ralpha-Stat6 signalling in lymphocytes and elevated serum IgE in patients with Graves' disease.
    Yabiku K; Hayashi M; Komiya I; Yamada T; Kinjo Y; Ohshiro Y; Kouki T; Takasu N
    Clin Exp Immunol; 2007 Jun; 148(3):425-31. PubMed ID: 17362266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of STAT6 promotes autoimmune disease and atopy on a susceptible genetic background.
    Lau M; Tsantikos E; Maxwell MJ; Tarlinton DM; Anderson GP; Hibbs ML
    J Autoimmun; 2012 Dec; 39(4):388-97. PubMed ID: 22867713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Learning while treating: Gain-of-function STAT6 variants in severe allergic disease.
    Smith TD; Doherty TA
    Cell Rep Med; 2023 May; 4(5):101040. PubMed ID: 37196636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential activation of signal transducer and activator of transcription 6 in B cells from allergic children and their non-allergic siblings.
    Deveikaite V; Fila C; Laurencikiene J; Klein E; Kihlström A; Lilja G; Ekström ES; Severinson E
    Clin Exp Allergy; 2004 Apr; 34(4):576-82. PubMed ID: 15080810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Polymorphism of Interleukin-4, Interleukin-4 Receptor and STAT6 in Children with Atopic Dermatitis in Taif, Saudi Arabia.
    Hussein YM; Alzahrani SS; Alharthi AA; Alhazmi AS; Ghonaim MM; Alghamdy AA; El Askary A
    Immunol Invest; 2016; 45(3):223-34. PubMed ID: 27018548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.
    Siegel AM; Stone KD; Cruse G; Lawrence MG; Olivera A; Jung MY; Barber JS; Freeman AF; Holland SM; O'Brien M; Jones N; Nelson CG; Wisch LB; Kong HH; Desai A; Farber O; Gilfillan AM; Rivera J; Milner JD
    J Allergy Clin Immunol; 2013 Dec; 132(6):1388-96. PubMed ID: 24184145
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Nam YK; Jin SC; Kim MH; Choi Y; Lee YB; Yang WM
    Molecules; 2020 May; 25(9):. PubMed ID: 32397290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected phenotype of STAT6 heterozygous mice implies distinct STAT6 dosage requirements for different IL-4 functions.
    Burgis S; Gessner A
    Int Arch Allergy Immunol; 2007; 143(4):263-8. PubMed ID: 17347574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Dupilumab.
    Harb H; Chatila TA
    Clin Exp Allergy; 2020 Jan; 50(1):5-14. PubMed ID: 31505066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of the STAT6-BCL6 antagonism by SWAP-70 determines IgE production.
    Audzevich T; Pearce G; Breucha M; Günal G; Jessberger R
    J Immunol; 2013 May; 190(10):4946-55. PubMed ID: 23589612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT6: A review of a signaling pathway implicated in various diseases with a special emphasis in its usefulness in pathology.
    Karpathiou G; Papoudou-Bai A; Ferrand E; Dumollard JM; Peoc'h M
    Pathol Res Pract; 2021 Jul; 223():153477. PubMed ID: 33991851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation by STAT6.
    Goenka S; Kaplan MH
    Immunol Res; 2011 May; 50(1):87-96. PubMed ID: 21442426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT6 variants and non-atopic asthma in Pakistani population.
    Riaz A; Ahsan Riaz M; Khan L; Shareef Masoud M; Hussain G; Iqbal M; Qasim M
    Cell Mol Biol (Noisy-le-grand); 2018 Nov; 64(14):15-18. PubMed ID: 30511616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.